-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ca6NO1ovYZ4jg02gbgH8mtwy9Rn7Bv7vuepTUM0aOR1oeQe0A2qrLw92ex8XNHZD kUm6o/vGWrIAmAhR/6j4Zw== 0001421000-10-000004.txt : 20100422 0001421000-10-000004.hdr.sgml : 20100422 20100422134218 ACCESSION NUMBER: 0001421000-10-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100422 DATE AS OF CHANGE: 20100422 EFFECTIVENESS DATE: 20100422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARCION THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001421000 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-140974 FILM NUMBER: 10764060 BUSINESS ADDRESS: STREET 1: 2400 BOSTON STREET, SUITE 330 CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: (410) 522-8701 MAIL ADDRESS: STREET 1: 2400 BOSTON STREET, SUITE 330 CITY: BALTIMORE STATE: MD ZIP: 21224 FORMER COMPANY: FORMER CONFORMED NAME: ARCION THEREAPEUTICS INC DATE OF NAME CHANGE: 20071212 D 1 primary_doc.xml X0704 D LIVE 0001421000 ARCION THERAPEUTICS, INC. 2400 BOSTON STREET, SUITE 330 BALTIMORE MD MARYLAND 21224 (410) 522-8701 DELAWARE ARCION THEREAPEUTICS INC Corporation true 2007 James Campbell c/o Arcion Therapeutics, Inc. 2400 Boston Street, Suite 330 Baltimore MD MARYLAND 21224 Executive Officer Director Kerrie Brady c/o Arcion Therapeutics, Inc. 2400 Boston Street, Suite 330 Baltimore MD MARYLAND 21224 Executive Officer Arnold Oronsky c/o Arcion Therapeutics, Inc. 2400 Boston Street, Suite 330 Baltimore MD MARYLAND 21224 Director Cynthia McCormick c/o Arcion Therapeutics, Inc. 2400 Boston Street, Suite 330 Baltimore MD MARYLAND 21224 Director David Collier c/o Arcion Therapeutics, Inc. 2400 Boston Street, Suite 330 Baltimore MD MARYLAND 21224 Director Biotechnology Decline to Disclose 06 false 2010-04-15 false true false 0 Indefinite 1250000 Indefinite false 3 0 0 0 The Issuer will use proceeds for general working capital purposes which includes payments to its executive officers and other employees in the ordinary course of business. false ARCION THERAPEUTICS, INC. /s/ Kerrie Brady Kerrie Brady Chief Operating Officer 2010-04-21 -----END PRIVACY-ENHANCED MESSAGE-----